How The FDA May Be Stifling Medical Innovation At Healthcare Startups
Regulatory burdens and healthcare reform are causing big uncertainties for venture investors that could limit the capacity of drug and medical device startups to bring products already in the pipeline to market.
Ray Leach | Posted 01.14.2012